NCT Number: NCT02439021
Effectiveness of the New Perilaryngeal Airway in Comparison With the Laryngeal Mask Airway
The Laryngeal Mask Airway (LMA) has been used widely for different patients and found to be highly safe for adult and pediatric patients. However, the LMA has some limitations and weaknesses (e.g. more insertion attempts in 5% to 10 % of all cases. Despite the easy insertion of the LMA, it is crucial to check correct placement of the LMA airway.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- BMI between 25 to 35 kg/m2
- scheduled for surgery
- being older than 18 years
- Mallampati class I-III and BMI between 25 and 35
Exclusion criteria
- pregnancy
- morbid obese (BMI>35 kg/m2)
- a known difficult airway
- gastro-oesophageal reflux
- pharyngeal pathology
- emergency operation with full stomach
Treatment and study plan
LMA
DevicePrimary outcomes
-
Oropharyngeal leak
Time frame: Up to 1 hours
-
Time to intubation
Time frame: Up to 1 hours
Time to intubation was measured from inserting of the device to the patient's month while connecting the breathing circuit
Secondary outcomes
-
successful intubation attempt
Time frame: Up to 1 hours
A successful intubation attempt was recognized if: the breathing circuit connected, the EtCO2 trace was revealed, and no air leak was detected at airway pressures of 15 cm H2O
-
incidence of sore throat
Time frame: Up to 1 hours
-
incidence of dysphasia
Time frame: Up to 1 hours
-
incidence of postoperative blood staining on mask
Time frame: Up to 1 hours
Sponsors and collaborators
Lead sponsor
Qazvin University Of Medical Sciences
Other
Registry information
Official study title
Effectiveness of the New Perilaryngeal Airway (CobraPLA™) in Comparison With the Laryngeal Mask Airway (LMA™) to Improve Oropharyngeal Leak Pressure Among Obese and Overweight Patients
Important dates
- Study start
- 2012
- Primary completion
- 2013
- First posted
- May 8, 2015
- Registry last updated
- May 8, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women
NCT00862433
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsInvestigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 Diabetes
NCT00065676
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsEMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
NCT05093634
Body Weight, Genetic Obesity
Phoenix, Arizona, United States
View Trial DetailsA Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
NCT06066528
Body Weight, Diabetes Mellitus
Anniston, Alabama, United States
View Trial Details